Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 2 , Pages 207-221, April 2008

Androgen biosynthetic pathways in the human prostate

Laboratory of Molecular Endocrinology and Oncology, Laval University Hospital Research Center, Laval University, 2785 Laurier Boulevard, Québec G1V 4G2, Canada

It is well recognized that there are two androgens, namely testosterone (T) and dihydrotestosterone (DHT); T plays an important role in the testis and muscle, and DHT is crucial for the development, function and pathology of the prostate. It is generally thought that DHT is produced from the 5α-reduction of circulating T before being inactivated by 3α-hydroxysteroid dehydrogenase (3α-HSD) that converts DHT into 5α-androstane-3α,17β-diol (3α-diol). However, the presence of various steroidogenic enzymes in the prostate as well as the availability at high levels of various steroid precursors such as dehydroepiandrosterone sulphate (DHEAS), dehydroepiandrosterone (DHEA) and 4-androstenedione (4-dione) strongly suggest the existence of additional pathways involved in the biosynthesis and metabolism of DHT. Because steroidogenesis could be different in different species, data from the literature obtained from various human, dog, rat and mouse prostate tissues, as well as primary cells and prostatic cancer cell lines, provide a somewhat confusing picture. In the present chapter, we review the data in order to provide a clearer picture of the pathways involved in DHT biosynthesis and metabolism in the human prostate.

Key words: prostate, sex steroids, androgen, oestrogen, dihydrotestosterone, oestradiol, steroidogenesis, intracrinology, androgen biosynthesis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-690X(08)00009-2

doi:10.1016/j.beem.2008.01.008

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 2 , Pages 207-221, April 2008